Novo Nordisk Foundation

The Novo Nordisk Foundation has just published its 2024 Grant Report, which gives an overview of our grant-giving for the year.   See the full report here: https://lnkd.in/dtp_M6aB

Artificial intelligence offers a glimpse into the future of medicine Can your DNA tell the whole story of your health? Not quite. A new study supported by the Novo Nordisk Foundation shows how AI can now read a deeper layer of biological code—our proteins. These “silent” changes don’t show up in your DNA but can play a major role in disease. The researchers behind InstaNovo and InstaNovo+ developed an algorithm that learns the language of protein fragments, finding clues that human biology—and traditional tools—have missed. This is more than a tech story. It’s a glimpse into the future of medicine. You can read the full article at ScienceNews.dk – a science platform providing articles, videos, and podcasts from the world of research. All content is based on research or researchers supported by the Novo Nordisk Foundation. #ScienceNewsdk #AIinBiotech #ProteinScience #FutureOfHealth #PrecisionMedicine Timothy Jenkins

The Novo Nordisk Foundation has allocated up to DKK 50 million to support academic use of the powerful Gefion AI supercomputer. The call is open to researchers affiliated with Danish academic research institutions. https://lnkd.in/d4x59nVM

The United Nations World Food Programme (WFP) is extending its existing partnership with the Novo Nordisk Foundation through a historic private-public sector collaboration that brings in the Ministry of Foreign Affairs of Denmark and the Grundfos Foundation | PDJF, to expand its home-grown school meals programme in Kenya, Rwanda, and Uganda.

New tool helps parents spot early signs of obesity in children Is your child just bigger than average — or at risk of obesity? A new calculator developed by researchers could change how parents, doctors, and public health professionals approach childhood weight. By taking into account age, sex, and normal variations in body composition, the tool offers a more accurate picture than BMI alone. This research is a step toward early, sensitive intervention — and away from stigma and guesswork. You can read the full article at ScienceNews.dk – a science platform providing articles, videos, and podcasts from the world of research. All content is based on research or researchers supported by the Novo Nordisk Foundation #ScienceNewsdk #ChildHealth #ObesityPrevention #PublicHealth #Pediatrics #HealthInnovation

🌱 Join us for an inspiring open lecture with Professor Julia Vorholt from ETH Zürich. We’re proud to welcome the 2025 Novonesis Biotechnology Prize recipient as she presents her groundbreaking work on synthetic communities in plant microbiome research – a field with important implications for future developments in agriculture and sustainability. Discover how beneficial microbes help plants grow stronger, fight disease, and adapt to environmental stress – much like our own gut bacteria. 📅 Date: 24 April 2025, 15:30–18:30 📍 Venue: Copenhagen Plant Science Center (CPSC), Bülowsvej 21a, 1871 Frederiksberg 🎟️ Free admission – open to all 📖 Lecture title: “Establishing Causality: Opportunities of Synthetic Communities for Plant Microbiome Research” 🗓️ Sign-up deadline: 22 April 2025 Sign up here: https://lnkd.in/dbha_3tZ #Biotechnology #Microbiome #Sustainability #PlantScience #NovonesisBiotechnologyPrize #Innovation ETH Zürich Julia V.

🎓 Join us for an open lecture with Professor Jean-Laurent Casanova – Novo Nordisk Prize Laureate 2025 The Novo Nordisk Foundation is pleased to invite you to an open lecture with Professor Jean-Laurent Casanova, recipient of the Novo Nordisk Prize 2025. The lecture is open to all and free of charge, but registration is required. 🗓 Date: 24 Apr 2025 / 15:00 - 18:00 📍 Venue: University of Copenhagen, Niels K. Jerne Auditorium, Panum, Blegdamsvej 3B, 2200 Copenhagen 🔗 Register here: https://lnkd.in/ddxqBGD4 🕓 Deadline: Please register no later than 21 April 2025. Seats are allocated on a first-come, first-served basis. About the lecture Professor Casanova’s research has significantly advanced our understanding of the genetic basis of infectious diseases. His work has led to the identification of more than 70 genes that, when mutated, increase susceptibility to specific infections—contributing to new approaches in diagnosis and treatment. #NovoNordiskPrize #HumanGenetics #InfectiousDiseases #Research Københavns Universitet - University of Copenhagen

Each year, millions suffer from venomous snakebites, leading to significant mortality and morbidity, especially in low-resource regions. Traditional antivenoms, derived from animal plasma, are costly, have limited efficacy against certain toxins, and are challenging to distribute in remote areas. Recent advancements have ushered in a new era of treatment. Scientists are now leveraging artificial intelligence to design synthetic proteins that neutralise venom toxins more effectively and affordably. These AI-designed antivenoms are stable, easier to produce, and hold the promise of being more accessible to those in need. This innovative approach not only enhances the efficacy of treatments but also addresses the logistical challenges faced in delivering timely care to snakebite victims. By harnessing the power of AI, we move closer to a future where life-saving antivenoms are within reach for all. The study was carried out by a team of scientists – including David Baker, who was awarded the Nobel Prize in Chemistry in 2024. You can read the full article at ScienceNews.dk – a science platform providing articles, videos, and podcasts from the world of research. All content is based on research or researchers supported by the Novo Nordisk Foundation. #ScienceNewsdk #SnakebiteTreatment #ArtificialIntelligence #Biotech

The Distinguished Innovator grant aims to create innovation role models in the Nordic countries while empowering them to translate their science-based discoveries within life sciences and the green transition into solutions that benefit people and society. At a recent networking event, over 30 Distinguished Innovators from across the Nordics came together to share their experiences and foster collaborations. Learn more: https://lnkd.in/emrcUYFG

"AMR is invisible, but we survivors are not." This #WorldTBday, we share the story of Bhakti Chavan, who overcame extensively drug-resistant tuberculosis (XDR-TB) and now advocates for patients as a member of the World Health Organization Task Force of AMR Survivors. Tuberculosis (TB) remains one of the world's deadliest infectious diseases. Antimicrobial resistance (AMR) is making TB even harder to treat, as it has developed resistance to many effective drugs, leading to significant antibiotic use. The Novo Nordisk Foundation is tackling AMR through initiatives like the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI), which aims to develop new or improved vaccines for deadly respiratory diseases, including tuberculosis. Learn more about NIVI here: https://nivi.ku.dk/